Cerebral blood flow velocity after mannitol infusion in children
Objectif: On ne sait trop si l'effet du mannitol sur la masse c~r~brale d~pend d'un mdcanisme hdmodynamique, rhdologique ou osmotique. Si le mannitol modifie l'hdmodynamique cdrdbrale en induisant la vasoconstriction, ce changement devrait se refl~ter sur la v~locit~ du ddbit sanguin c~rdbral (VDSC) mesur~e dans l'art~re cdrdbrale moyenne (ACM). L'objectif de ce travail dtait d'dvaluer chez l'enfant l 'effet du mannitol sur la VDSC. Mdthodes: L'dtude portait sur des enfants programmds pour une intervention intracr~nienne. Apr~s une dose de charge de I0 pg. kg -t de fentanyl, l'anesthdsie a dtd entretenue avec du fentanyl (3 iJg.kg-l.h-t), du protoxyde d'azote ~ 66% et de l'isoflurane (inspird 0,2-0,5%). La VDSC moyenne et systolique (Vm et Vs) et l'index pulsatile (IP) on ~td enregistrcSs grdce ~ un DOppler transcr6nien (DTC) dirigd vers le segment MI de I'ACM. Le mannitol (1 g .hg -I ) a dtd administr~ en 15 rain. L'osmolalitd (Osm)
Mannitol has been a mainstay in the reduction of brain bulk in neurosurgical patients for decades. Controversy exists, however, regarding the mechanism by which such infusions exert their benefits. While osmotic mechanisms have been presumed since the first studies of gations have demonstrated that mannitol administration also produces haemodilution, diminishes blood viscosity, and increases cerebral blood flow. 3-5 These features, along with increases in cardiac filling pressures and output have led some investigators to suggest that the resultant autoregulatory cerebral vasoconstriction, rather than osmotic dehydration, is responsible tor much of the observed reduction in brain bulk.
Haemodynamic mechanisms for the effects of mannitol infusion rest upon the assumption that cerebral vasoconstriction occurs with its intravenous administration. 6 We hypothesized that this vasoconstriction should be detectable by Doppler ultrasonography and that this technology should provide a suitable means by which human data regarding this phenomenon may be obtained directly. We therefore sought to describe the changes in cerebral blood flow velocity (CBFV) in patients receiving mannitol infusions for reduction of brain bulk during neurosurgical procedures to assess whether vasoconstriction occurs.
Methods

Patient population
After approval from the Human Subjects Review Board Committee and informed parental consent, l0 children aged I to 14 yr scheduled for intracranial surgery were studied. Exclusion criteria included evidence of intracranial hypertension or haemorrhage.
Anaesthetic management
After appropriate fasting, patients were monitored before induction with a sphygmomanometer, ECG, infrared gas monitor, precordial stethoscope, pulse oximeter and temperature probe. General anaesthesia was induced using either an inhalation technique with halotha.ne, nitrous oxide and oxygen or an iv technique with thiopentone. Neuromuscular blockade was achieved using pancuronium (0.1 mg-kg-I), the trachea was intubated and the lungs were mechanically ventilated to maintain end-tidal carbon dioxide (ETCO 2) at 25-30 mmHg. After a loading dose of fentanyl (10 pg.kg-~), anaesthesia was maintained with fentanyl (3 pg-kg-l-hr-~), isoflurane (0.2-0.5% inspired) and nitrous oxide and oxygen (2:1 ratio). Normothermia was maintained using a passive humidifier and wanning blanket.
Determination of cerebral blood flow velocity
Cerebral blood flow velocity was measured noninvasively by transcranial Doppler ultrasonography using a Medasonics CDS (Medasonics, Fremont, CA). The transducer probe was fixed to the neurosurgical head frame and placed over the temporal window contralateral to the operative site to display flow velocity from the MI segment of the middle cerebral artery (MCA). To confirm the position of the MI segment, the MCA signal was accompanied in every case with retrograde anterior CBFV (A I segment). A range-gated pulsed Doppler probe (area = 1.5 cm 2) with a frequency of 2 MHz, emitting power of 100 mW, resolution of 3 cm.sec -I was used. The frequency spectrum of Doppler signals, displayed on a frequency analyzer in real time was stored and analyzed at a later date. Mean and systolic CBFV (Vm and Vs) and the pulsatility index (PI) were determined. The Vm, Vs, and PI were measured at end-expiration to minimize the effects of positive pressure ventilation.
The Vm and PI are calculated values. The Vm is determined by computer analysis using fast-Fourier analysis to obtain time averaged values of the spectral edge. Since the envelope of the Doppler waveform corresponds to the maximum flow velocities at the centre of the vessel, the envelope of the spectra is used to calculate the mean velocities for the last five cardiac cycles. The lowest averaged frequency values for the same cardiac cycles are considered the end diastolic velocities (Vd). The PI was calculated as: PI = VsVd/Vm.
Experimental procedure
Each patient served as his/her own control. The Vm, Vs, and PI were determined, as discussed above, after the patient's skull was fixed on the head frame. This was approximately 20 min after induction of anaesthesia. In order to measure the effect of mannitol on blood rheology and arterial blood gases, the carbon dioxide tension (PaCO 2) and haematocrit (Hct) were determined on a Nova Stat Profile 9 (Nova Biomedical, Waltham, MA). Osmolality (Osm) was measured on a microosomometer (Advanced Instruments, Norwood, MA). All measuremerits were recorded prior to the infusion of mannitol (I g.kg-~), after completion of the mannitol infusion (15 min) and at 30, 45, and 60 rain. Surgical manipulations were avoided during this 60 min measurement period.
Statistical analysis
Data are reported as means _. + standard deviation (SD). In order to minimize interindividual variability of physiological responses, we compared baseline values with subsequent measurements after the administration of mannitol. Changes in Osm, Hct, MAP, HR, Vm and PI were compared with each subject's baseline value with repeated measures ANOVA and the Dunnett post-hoc test. Nonlinear regression was performed on the relative values (% change from control) of the haematocrit and Data are presented as mean • SD. Mean arterial pressure = MAP; heart rate = HR; partial pressure of arterial carbon dioxide = PaCO2; systolic cerebral blood flow velocity = CBFVs; mean cerebral blood flow velocity = CBFVm; pulsatility index = PI. *P < 0.05, "t'P < 0.01. Vs using commercially available statistics software (SigmaStat, Jandel, San Rafael, CA). Statistical significance was accepted as P < 0.05.
Results
Ten children aged 9.0 _ 4.2 yr (five girls and five boys, age range: 0.8 to 14 yr) and weighing 33.2 _ 19.7 kg were included in the study. The PaCO2 and cardiovascular variables such as HR and MAP did not change during the measuring period (Table) . Plasma Osm increased beginning at the 15 min measurement and lasting throughout-the 60 min study period. The Hct decreased at 15 min and returned to baseline by 45 min (Figure !) .
The Vs and PI increased and reached maximal values 15 min after the administration of mannitol (Figure 2 ).
There was a trend for Vm to increase during the same period but this did not reach .statistical significance. All variables returned to baseline values by 45 min.
We found a high correlation between the haematocrit and Vs (Figure 3) . The relationship between these variables can be expressed as Vs = 1.72 r x Hot (r = 0.608, P < 0.0001).
Discussion
This study sought to demonstrate the CBFV correlates of a haemodynamic effect of mannitol. We observed that although Vs and PI increased after mannitol (1 g. kg-~), Vm did not change. Alterations in CBFV were rapid and brief with maximal changes within 15 min and complete return to baseline within 45 min. The time course of these changes closely parallels previously reported cerebral haemodynamic and arterioIar vessel diameter changes described in an animal model. 6 Therefore, our data support a haemodynamic mechanism for the early effects of mannitol in humans.
Mannitol, by decreasing blood viscosity, increases CBF. 7-9 Haematocrit determines blood flow especially in narrow vessels. Haemodilution leads to increased blood flow by two mechanisms. Reduction in haematocrit leads to less erythrocyte aggregation and improved laminar flow. Mannitol also reduces rigidity of the erythrocyte and enhances passage through small blood vessels. ~~ Although the osmolality remained elevated during the 60 min study period, the haematocrit returned to control levels at 45 min. Although other investigators have described this phenomenon, its mechanism is still unclear. ~.~2 We also found a high inverse correlation between the haematocrit and Vs. These mannitolinduced changes on blood rheology facilitates cerebral perfusion by reducing blood viscocity.
Direct intravital microscopy of pial vessels demonstrates vasoconstriction in response to mannitol. 6 This phenomenon has also been observed during isovolaemic haemodilution with plasma. 7 Vascular beds with high distal resistance have high Pl. ~3 Proximal arteries have been shown to dilate, albeit minimally, as an autoregulatory response to increasing peripheral resistance. In our study, plasma Osm and Hct changed but the Vm was unchanged after the mannitol infusion. The concurrent increase in the Vs and PI immediately after the mannitol infusion suggests that the vessels distal to the insonated artery were vasoconstricting in response to the mannitol infusion. Since we controlled factors that alter CBF such as ETCOz, blood pressure, temperature and concentration of inhaled anaesthetic agents, the effect of mannitol either directly or indirectly (by changing the Hct and Osm) may account for our observed cerebral haemodynamic changes. Constriction of the pial arteries in coinbination with vasodilation in the proximal conducting arteries would result in the observed increase in the Vs and PI and stability of Vm. We propose that the M I segment of the MCA minimally dilated in response to mannitol infusion. This phenomenon would account for the statistically insignificant rise in Vm, and significant rise in Vs and PI. We believe that vasodilatation of the basal cerebral arteries serves as an autoregulatory response in order to maintain constant microvascular perfusion. In our study, we used TCD to measure CBFV in a single vessel, the MCA. The use of TCD as an index of cerebral perfusion depends on the ability of the Vm to correlate with cerebral blood flow (CBF). This, amongst other considerations, depends on the cross sectional area of the M I or the precommunicating segment of the MCA remaining constant. If the diameter of the M 1 segment remains constant, any change in Vm would reflect proportional changes in the CBF. The reproducibility of CBFV measurements with the TCD has been demonstrated in children anaesthetized with isoflurane and nitrous oxide 9 As expected, Vm increased after the infusion of man-nitol, but this increase did not reach statistical significance. One possible explanation for this is that the diameter of the MI segment may not be fixed as previously thought. It has been suggested that pharmacological and autoregulatory factors can alter the diameter of the MCA. t7 Nitroglycerin has been shown to reduce Vm without changing regional CBF, suggesting that nitroglycerin causes vasodilation of basal intracranial arteries. '8 Furthermore, direct measurements of the M I segment of the MCA during changes in PaCO2 and blood pressure have revealed 2% variability in the vessel diameter in two patients with cerebrovascular disease. 19 Although these findings were not clinically important, the suitability of using alterations in Vm to reflect accurately changes in CBF during such physiological changes in the M I diameter has been questioned. 2~ Increases in vessel diameter would increase the cross sectional area of the vessel. Since CBF is equal to the product of the cross sectional area and the Vm, if the CBF is stable increases in the cross sectional area would decrease Vm. The use of Vm as an estimate of cerebral perfusion is made on the assumption that the vessel diameter remains constant during the measuring period and vasodilatation will under estimate the true value of Vna. 17 In this study, CBFV was monitored for 60 min as a convenient observation period betore surgical manipulation. Due to its invasive nature, we did not believe that it was ethical to perform direct intracranial pressure (ICP) measurements in our study. Based upon previous animal data, a 60 rain observation period was chosen to allow sufficient time to begin to detect rebound effects upon the cerebral circulation and ICP. For example, Muizelaar et al. described a 20% rebound of ICP above baseline in cats 60 rain after mannitol infusion yet only a 5% rebound of arteriolar diameter in the same period. 6 Here, we observed a similar absence of rebound changes in CBFV by 60 rain in children receiving mannitol. While small differences might be expected to remain below the threshold of detection, on the basis of these data, it remains likely that the major determinants of the rebound phenomenon are non-vascular in nature and occur beyond the observation period in this study. Potential alternative mechanisms for ICP rebound include changes in cerebrospinal fluid dynamics, alterations in blood-brain barrier osmotic gradients, and direct cellular swelling. 6.2L22
In conclusion, we have described the cerebral haemodynamic effects of mannitol in children determined by transcranial Doppler sonography. The time course of changes in CBFV closely corresponds to previous animal data concerning cerebrovascular tone following mannitol infusion. Since Vs and PI peaked at the same time, we speculate that large conducting arteries dilated acutely either in direct response to changes in plasma osmolality or as part of an autoregulatory response to increased peripheral resistance. Although we did not directly investigate the vascular mechanism of this phenomenon, these findings suggest that vasoconstriction of peripheral vessels leads to a transient decrease in cerebral blood volume. This transient decrease in cerebral blood volume, can account for the reduction in brain bulk after mannitol.
